logo

Chemotherapy Research and Practice

Chemotherapy Research and Practice / Table of Contents

Table of Contents

Table of Contents

  • Chemotherapy Research and Practice -
  • Special Issue
  • Volume 2012
  • - Article ID 283181
  • - Review Article

Integrin Signaling in Cancer Cell Survival and Chemoresistance

Fawzi Aoudjit | Kristiina Vuori
  • Chemotherapy Research and Practice -
  • Special Issue
  • Volume 2012
  • - Article ID 858590
  • - Clinical Study

Bone Loss after Allogeneic Haematopoietic Stem Cell Transplantation: A Pilot Study on the Use of Zoledronic Acid

Andreas Hausmann | Wolfgang Hill | ... | Johanna Tischer
  • Chemotherapy Research and Practice -
  • Special Issue
  • Volume 2012
  • - Article ID 913848
  • - Research Article

Healthcare Costs and Workloss Burden of Patients with Chemotherapy-Associated Peripheral Neuropathy in Breast, Ovarian, Head and Neck, and Nonsmall Cell Lung Cancer

Crystal T. Pike | Howard G. Birnbaum | ... | Ronald B. Natale
  • Chemotherapy Research and Practice -
  • Special Issue
  • Volume 2012
  • - Article ID 721873
  • - Research Article

Methodology for Anti-Gene Anti-IGF-I Therapy of Malignant Tumours

Jerzy Trojan | Yuexin X. Pan | ... | Donald D. Anthony
  • Chemotherapy Research and Practice -
  • Special Issue
  • Volume 2012
  • - Article ID 192362
  • - Review Article

β-Catenin Signalling in Glioblastoma Multiforme and Glioma-Initiating Cells

Mireia Nager | Deepshikha Bhardwaj | ... | Judit Herreros
  • Chemotherapy Research and Practice -
  • Special Issue
  • Volume 2011
  • - Article ID 965826
  • - Research Article

Development of an Oral Form of Azacytidine: Triacetyl-5-Azacytidine

Amy Ziemba | Eugene Hayes | ... | Giuseppe Pizzorno
  • Chemotherapy Research and Practice -
  • Special Issue
  • Volume 2011
  • - Article ID 878912
  • - Review Article

New Agents Targeting Angiogenesis in Glioblastoma

Eleni Timotheadou
  • Chemotherapy Research and Practice -
  • Special Issue
  • Volume 2011
  • - Article ID 218431
  • - Research Article

Escherichia coli Isolated from Urinary Tract Infections of Lebanese Patients between 2000 and 2009: Epidemiology and Profiles of Resistance

Ziad Daoud | Claude Afif
  • Chemotherapy Research and Practice -
  • Special Issue
  • Volume 2011
  • - Article ID 602812
  • - Clinical Study

Bevacizumab Improves Quality of Life in Patients with Recurrent Glioblastoma

Seema Nagpal | Griffith Harsh | Lawrence Recht
  • Chemotherapy Research and Practice -
  • Special Issue
  • Volume 2011
  • - Article ID 730360
  • - Review Article

Role of HER2-Targeted Agents in Adjuvant Treatment for Breast Cancer

Toru Mukohara
  • Chemotherapy Research and Practice -
  • Special Issue
  • Volume 2011
  • - Article ID 839742
  • - Review Article

Neoadjuvant Treatment in Rectal Cancer: Actual Status

Ingrid Garajová | Stefania Di Girolamo | ... | Giovanni Brandi
  • Chemotherapy Research and Practice -
  • Special Issue
  • Volume 2011
  • - Article ID 843019
  • - Review Article

Neurotoxicity Caused by the Treatment with Platinum Analogues

Sousana Amptoulach | Nicolas Tsavaris
  • Chemotherapy Research and Practice -
  • Special Issue
  • Volume 2011
  • - Article ID 696208
  • - Review Article

Triple-Negative Breast Cancer: Adjuvant Therapeutic Options

Ayca Gucalp | Tiffany A. Traina
  • Chemotherapy Research and Practice -
  • Special Issue
  • Volume 2011
  • - Article ID 163736
  • - Case Report

A Regimen of Taxol, Ifosfamide, and Platinum for Recurrent Advanced Squamous Cell Cancer of the Anal Canal

Diana V. Golub | A. Cahid Civelek | Vivek R. Sharma
  • Chemotherapy Research and Practice -
  • Special Issue
  • Volume 2011
  • - Article ID 270932
  • - Research Article

Activity of Antimicrobial Peptides and Conventional Antibiotics against Superantigen Positive Staphylococcus aureus Isolated from the Patients with Neoplastic and Inflammatory Erythrodermia

Wioletta Baranska-Rybak | Oscar Cirioni | ... | Wojciech Kamysz

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.